NCT05431504 2022-06-24The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral CrisisCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting53 enrolled